Boardroom Alpha
Boardroom Alpha
ALX · Current Report (Form 8-K) · Filed March 9, 2026

Alexanders Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 9, 2026
Period
Mar 6, 2026
Ticker
ALX
Accession
0000003499-26-000010
Boardroom Alpha · Filing insights

Alexander’s subsidiary to sell Rego Park I to Northwell for $235.5M; net proceeds ~$202M, closing by Q3 2026.

About Alexanders Inc
Market cap
$1.3B
1Y TSR
+15.4%
3Y TSR
+19.4%
Board grade
C-
Sector
Real Estate
CEO
Steven Roth
Last annual meeting: May 21, 2026 · View full Alexanders Inc profile →
alx-20260306


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 6, 2026

ALEXANDERS INC
(Exact Name of Registrant as Specified in Charter)
Delaware
001-06064
51-0100517
(State or Other
(Commission
(IRS Employer
Jurisdiction of Incorporation)
File Number)
Identification No.)
210 Route 4 East
Paramus,
New Jersey
07652
(Address of Principal Executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (201) 587-8541
Former name or former address, if changed since last report: N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2.):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $1 par value per share
ALX
New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 1.01.    Entry into a Material Definitive Agreement.                               
On March 6, 2026, Alexander’s Rego Shopping Center LLC, a wholly-owned subsidiary of Alexander’s, Inc. (the “Company”), entered into an Agreement of Purchase and Sale (the “Agreement”) with Northwell Health, Inc. (“Northwell”) to sell its Rego Park I shopping center (“Rego Park I”) located in Queens to Northwell for $235.5 million in cash payable upon closing. The Company expects to receive net proceeds of $202 million.
The sale includes a vacant, three-story, 338,000 gross leasable square foot structure built in 1959 and a 1,236 space parking garage, located on 5.9 acres in Queens, New York. The Agreement contains customary representations, warranties, covenants, and indemnification for breaches of representations and warranties and other matters. The sale is subject to customary closing conditions and is expected to close by the third quarter of 2026.
This disclosure summarizes the material provisions of the Agreement. This summary is qualified in its entirety by reference to the full text of the Agreement which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
Item 7.01.    Regulation FD Disclosure.   

A copy of the Company’s press release announcing the entry into the Agreement is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or under the Exchange Act.
Item 9.01.    Financial Statements and Exhibits. 
Exhibit No.Description
Press Release, dated March 9, 2026.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).


2



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ALEXANDER’S, INC.
(Registrant)
 By:/s/ Gary Hansen
 Name:Gary Hansen
 Title:Chief Financial Officer (duly
authorized officer and principal financial and accounting officer)
 
Date: March 9, 2026
 


3

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Alexanders Inc (ALX)

Reference

Frequently asked questions

When did Alexanders Inc file this 8-K?
Alexanders Inc (ALX) filed this Current Report (Form 8-K) with the SEC on March 9, 2026. The accession number assigned by EDGAR is 0000003499-26-000010.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Alexander’s subsidiary to sell Rego Park I to Northwell for $235.5M; net proceeds ~$202M, closing by Q3 2026. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Alexanders Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Alexanders Inc has filed under CIK 3499, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer